Of note, the fibronectin-mediated protective effect against cytosine arabinoside treatment proved to be stronger in CD157-positive than in CD157-negative U937 cells (S.A., personal observation), suggesting that CD157 has a role in facilitating leukemia cell interactions with extracellular matrix components and modulates the sensitivity of AML cells to chemotherapy, at least in vitro. The gene discussed is BST1; the disease is leukemia.